Thymalfasin has been marketed as Zadaxin in countries where it holds approval, but it has not been approved by the FDA or EMA. It has been studied in hepatitis B, hepatocellular carcinoma, and seps...
View full compound profile →Vendors stocking
11
across 4 countries
Total listings
15
14 in stock
Price range
£26.95–£79.90
Median price per mg
£5.99
Most common size
5mg
8 listings
Stock health
93%
11 vendors · 14 listings
5mg
8 listings
Avg price: £36.98
Avg per mg: £7.40
10mg
3 listings
Avg price: £44.65
Avg per mg: £4.46
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 11 vendor websites across 4 countries
